stockportfolio.pro
Stocks / PEN vs SOLV
PEN vs SOLV
Penumbra, Inc. and Solventum Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
SOLV is the larger company ($12.9B vs $12.6B). On the fundamentals, PEN grows revenue faster (20.2% vs 0.8%); SOLV earns a higher net margin (18.7% vs 12.7%); SOLV has the stronger return on equity (30.8% vs 12.4%). Full numbers below — the stronger figure on each row is in green.
| Penumbra, Inc. (PEN) | Solventum Corporation (SOLV) | |
|---|---|---|
| Market cap | $12.6B | $12.9B |
| Revenue (latest FY) | $1.40B | $8.32B |
| Net income (latest FY) | $177.69M | $1.56B |
| Revenue growth (5y CAGR) | 20.2% | 0.8% |
| Net margin | 12.7% | 18.7% |
| Return on equity | 12.4% | 30.8% |
| P/E ratio | 73.8 | 9.1 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 8 | 4 |
| Positive free cash flow | Yes | No |
Compare with another company:
See the full PEN vs SOLV breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open PEN's full financials → Open SOLV's full financials →More comparisons
Frequently asked questions
Which is bigger, PEN or SOLV?
Solventum Corporation is larger by market capitalization — $12.9B versus $12.6B.
Which grows faster, PEN or SOLV?
Over the last five fiscal years, Penumbra, Inc. grew revenue faster — 20.2%/yr versus 0.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.